THE HUMAN ANTIBODY RESPONSE TO SIMULTANEOUS INJECTION OF SIX SPECIFIC POLYSACCHARIDES OF PNEUMOCOCCUS by Heidelberger, Michael et al.
THE  HUMAN ANTIBODY RESPONSE TO  SIMULTANEOUS 
INJECTION  OF SIX SPECIFIC  POLYSACCHARIDES 
OF PNEUMOCOCCUS* 
By  MICHAEL HEIDELBERGER,  PH.D.,  COLIN M.  MAcLEOD, M.D.,  AND 
MARIE M.  Dr  LAPI 
(From the Department of Medicine, College of Physicians and Surgeons, Columbia 
University, and the Department of Microbiology, New York 
University College of Medicine, New York) 
(Received for publication, June 16, 1948) 
Previous quantitative studies of the antibody content of the sera of human 
beings injected with immunizing  (1)  doses of the specific polysaccharides of 
pneumococcus have dealt with analyses of sera after injection of two or three 
(reference 2) and four (reference 3) specific polysaccharides at one time.  Since 
it was feasible for practical purposes to combine into a single solution as many 
as six polysaccharides of the pneumococcal types most commonly responsible 
for pneumococcal pneumonias in man, exact knowledge of the antibody response 
to the  injection of so many chemically similar antigens  appeared desirable. 
Data obtained with two different combinations of six polysaccharides are given 
in the present report. 
EXPEI~  r~r~.NTAL 
Medical  student  volunteers,  after  a  preliminary  bleeding  (subscript  0),  were  injected 
subcutaneously with  1 ml. of a  solution containing about 0.07  mg. each of six type-specific 
polysaccharides of pneumococcus.  Subjects 201 to 206 received the specific polysaccharides of 
Types I, II, III, V, VII, VIII pneumococcus, these being the types most common in pneumo- 
coccal pneumonia of adults,  while Nos. 207  to 212  received Types I, IV, VI, XIV, XVIII, 
XIX, the types most common in the pneumococcal pneumonias of children.  Both antigen 
solutions were prepared by E. R. Squibb and Sons.  Subject J, a woman 63 years of age, re- 
ceived the first solution.  Nine months after its injection, sample Jt was  taken,  when  the 
antibodies formed were probably no longer at peak levels (2).  From the other subjects  a 
bleeding (subscript 1) was taken 6 weeks to 2 months after the injections.  Analyses on sera 
202x and  210x could not be completed owing to  accidental  contamination,  and  additional 
samples 2022 and 210~ were procured 9.5 and 5.5 months after injection, respectively. 
Analyses were carried out according to the method mentioned in reference 4 and described 
in detail in reference 2.  Precautions against bacterial contamination were taken owing to the 
large number of successive analyses required and the long standing necessary for each analysis. 
Superscripts after values for antibody nitrogen indicate an unusually large number of absorp- 
tions for complete removal of the antibody in  question. 
* The work reported in this communication was carried out in part under the Harkness 
Research Fund of the Presbyterian Hospital and was also supported through the Commission 
on Acute Respiratory Diseases, Army Epidemiological Board, Office of The Surgeon General, 
United States Army. 
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DISCUSSION 
The analytical values for the type-specific antibody content of the sera of hu- 
man beings injected subcutaneously with a mixture of six type-specific polysac- 
charides of pneumococcus resemble those obtained in earlier quantitative micro- 
TABLE I 
Micrograms Antibody Nitrogen Per 4 Ml. Pre- and Post-Immunization  Sera of 
Subjects Injected with Specific Polysaccharides of Pneumococcus Types 
I, H, IH, V, VII, and VIII, 0.05 to 0.1 Mg. Each 
Antibody  C III  C VI 
to  .......... 
201o  19  17 
2011  53 
202o  27  21 
2021  35 
2022  40 
2030  39  30 
2031  52 
2040  20  14 
2041  16 
205o  46 
2051  62 
2060  32 
2061  28 
Jo  23 
Jl  16  15 
SI 
0 
31 
0 
3,. 
0 
33 
0 
3 
0 
15 
0 
8 
0 
13 
S  II 
5 
64 
3 
21 
I 
33 
0 
6 
0 
21 
0 
18 
0 
10, 6 
S Ill 
4*, 4 
(14)~ 
1", 11 
4*, 3 
21 
0", 0 
2 
1" 
11 
0* 
5 
4* 
12", 16 
S V  S VII 
0 
494 
0 
0, 0 
0 
107 
0 
0 
0  <301 
0, 8 
S VIII 
4, 3 
7 
0, 0 
6 
4, 1 
0, 0 
39  s 
0, 0 
S XIV 
3 
11 
C III=  C-substance  derived from Type III pneumococcus, C VI, from Type VI; S i, S 
II, etc., refer to type-specific polysaccharides. 
* Mter removal of anti-C with C-substance derived from Type III and possibly containing 
traces of SIII. 
:~ Last analysis before contamination noted. 
analytical studies of the sera of subjects injected with two or three or four of the 
antigens at a  time (2, 3).  The total  antibody response and the production of 
antibody to each antigen injected appeared to  be as satisfactory as in the sub- 
jects treated with smaller numbers of polysaccharides.  Variability of response 
and unequal reactivity of an  individual to all of the type-specific polysaccha- 
rides in the mixture were encountered as frequently as in the previous series. 
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one-haft of the subjects showed increases in the anti-C content of their sere after 
the injections.  Since almost all of the specific polysaccharides contain C-sub- 
stance as impurity, it is possible that the intensity of the antigenic stimulus for 
production of additional amounts of anti-C increases with the number of poly- 
saccharides  used,  and,  hence,  the probably greater quantity  of C-substance 
injected.  Whether or not all of this or only a portion is antigenic in man is not 
known. 
TABLE  n 
Micrograms Antibody Nitrogen Per 4 ml. Sera of Subjects Injected with Specific 
Polysaccharides of Pneumococcus Types I, IV, VI, XIV, XVII[, and XIX, 
0.05 go 0.1 Mg. Each 
212o 
2121 
Antibody  C  '  S I  1  to  ..........  ]  S [II* 
207o  27  0  I  0 
2071  26  54 
208o  6  0 
2081  55  s  24 
209o  31  0 
2091  89  24 
210o  87  0 
2101  58  50 
210,,  99  26 
211o  29  0 
2111  32  5 
56  4 
57  19 
o 
9 
o 
64 
2 
8~ 
o 
3 
:1 
o 
s 
1 
5 
VI  S XIV 
0  f  0 
2  47 
0  0 
4  0 
1  4 
L8  56 
7 
23 
4 
9 
6 
7O 
S XVIII 
3 
9 
5 
52 
5 
11 
16 
35 
0 
5 
2 
9 
S XIX 
0 
6 
0 
0 
1 
158 
0 
44' 
0 
0 
0 
14 
* SIII was not in the mixture injected.  Additional data on normals were sought. 
Attention is also directed to the relatively large proportion of the subjects 
whose pre-immunization sere  contained  measurable  quantities  of antibodies 
which precipitate with the specific polysaccharides of Types XIV and XVIII 
pneumococcus. 
SU~rt~ARY 
1.  The  antibody response in human beings after the injection of six type- 
specific polysaccharides of pneumococcus appears to be roughly of the same 
magnitude for each type as after the injection of fewer antigens. 
2.  A larger proportion of increases in anti-C was noted in the present series. 372  ANTIBODY  RESPONSE  TO  SIX  PN'EDMOCOCCUS  POLYSACCHARIDES 
3.  Many of the pre-immunization sera tested contained antibodies reactive. 
with the specific polysaccharides of Types XIV and XVIII pneumococcus. 
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